1
|
Njekwa K, Muyoyeta M, Mulenga B, Chisenga CC, Simuyandi M, Chilengi R. Superimposed Pulmonary Tuberculosis (PTB) in a 26-Year-Old Female with No Underlying Co-Morbidities Recovering from COVID-19-Case Report. Trop Med Infect Dis 2023; 8:tropicalmed8050268. [PMID: 37235316 DOI: 10.3390/tropicalmed8050268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Revised: 04/16/2023] [Accepted: 04/26/2023] [Indexed: 05/28/2023] Open
Abstract
Tuberculosis before the COVID-19 pandemic is said to have killed more people globally than any other communicable disease and is ranked the 13th cause of death, according to the WHO. Tuberculosis also still remains highly endemic, especially in LIMCs with a high burden of people living with HIV/AIDS, in which it is the leading cause of mortality. Given the risk factors associated with COVID-19, the cross similarities between tuberculosis and COVID-19 symptoms, and the paucity of data on how both diseases impact each other, there is a need to generate more information on COVID-19-TB co-infection. In this case report, we present a young female patient of reproductive age with no underlying comorbidities recovering from COVID-19, who later presented with pulmonary tuberculosis. It describes the series of investigations performed and treatments given during the follow-up. There is a need for more surveillance for possible COVID-19-TB co-infection cases and further research to understand the impact of COVID-19 on tuberculosis and vice versa, especially in LMICs.
Collapse
Affiliation(s)
- Katanekwa Njekwa
- Center for Infectious Disease Research in Zambia (CIDRZ), P.O. Box 34681, Lusaka 10101, Zambia
| | - Monde Muyoyeta
- Center for Infectious Disease Research in Zambia (CIDRZ), P.O. Box 34681, Lusaka 10101, Zambia
- Tuberculosis Programs-Director, Centre for Infectious Disease Research, P.O. Box 34681, Lusaka 10101, Zambia
| | - Bavin Mulenga
- Center for Infectious Disease Research in Zambia (CIDRZ), P.O. Box 34681, Lusaka 10101, Zambia
| | | | - Michelo Simuyandi
- Center for Infectious Disease Research in Zambia (CIDRZ), P.O. Box 34681, Lusaka 10101, Zambia
- Enteric Diseases and Vaccine Research Unit (EDVRU)-Director, P.O. Box 34681, Lusaka 10101, Zambia
| | - Roma Chilengi
- Center for Infectious Disease Research in Zambia (CIDRZ), P.O. Box 34681, Lusaka 10101, Zambia
- Zambia National Public Health Institute (ZNPHI)-Director, H9M2+WGX, Lusaka 10101, Zambia
| |
Collapse
|
2
|
Ali RM, Tharwat AI, Labib HA. Effect of Aspirin Use on clinical Outcome among Critically Ill Patients with COVID- 19. Egyptian Journal of Anaesthesia 2022. [DOI: 10.1080/11101849.2022.2139104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Affiliation(s)
- Rania M. Ali
- Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Ayman I. Tharwat
- Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Heba A. Labib
- Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| |
Collapse
|
3
|
Eldaboosy S, Almoosa Z, Saad M, Al Abdullah M, Farouk A, Awad A, Mahdy W, Abdelsalam E, Nour SO, Makled S, Shaarawy A, Kanany H, Qarah S, Kabil A. Comparison Between Physiological Scores SIPF, CURB-65, and APACHE II as Predictors of Prognosis and Mortality in Hospitalized Patients with COVID-19 Pneumonia: A Multicenter Study, Saudi Arabia. Infect Drug Resist 2022; 15:7619-7630. [PMID: 36582451 PMCID: PMC9793736 DOI: 10.2147/idr.s395095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Accepted: 12/14/2022] [Indexed: 12/24/2022] Open
Abstract
Background A coronavirus pandemic (COVID-19) is associated with catastrophic effects on the world with high morbidity and mortality. We aimed to evaluate the accuracy of physiological shock index (SIPF) (shock index and hypoxemia), CURB -65, acute physiology, and chronic health assessment II (APACHE II) as predictors of prognosis and in-hospital mortality in patients with COVID-19 pneumonia. Methods In Saudi Arabia, a multicenter retrospective study was conducted on hospitalized adult patients confirmed to have COVID-19 pneumonia. Information needed to calculate SIPF, CURB-65, and APACHE II scores were obtained from medical records within 24 hours of admission. Results The study included 1131 COVID-19 patients who met the inclusion criteria. They were divided into two groups: (A) the ICU group (n=340; 30.1%) and (B) the ward group (n=791; 69.9%). The most common concomitant diseases of patients at initial ICU admission were hypertension (71.5%) and diabetes (62.4%), and most of them were men (63.8%). The overall mortality was 18.7%, and the mortality rate was higher in the ICU group than in the ward group (39.4% vs 9.6%; p < 0.001). The SIPF score showed a significantly higher ability to predict both ICU admission and mortality in patients with COVID-19 pneumonia compared with APACHE II and CURB -65; (AUC 0.89 vs 0.87; p < 0.001) and (AUC 0.89 vs 0.84; p < 0.001) for ICU admission and (AUC 0.90 vs 0.65; p < 0.001) and (AUC 0.90 vs 0.80; p < 0.001) for mortality, respectively. Conclusion The ability of the SIPF score to predict ICU admission and mortality in COVID-19 pneumonia is higher than that of APACHE II and CURB-65. The overall mortality was 18.7%, and the mortality rate was higher in the ICU group than in the ward group (39.4% vs 9.6%; p < 0.001).
Collapse
Affiliation(s)
- Safwat Eldaboosy
- Department of Chest Diseases, Faculty of Medicine, Al-Azhar University, Cairo, Egypt,Department of Pulmonary Diseases, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia
| | - Zainab Almoosa
- Department of Infectious Diseases, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia
| | - Mustafa Saad
- Department of Infectious Diseases, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia
| | - Mohammad Al Abdullah
- Department of Infectious Diseases, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia
| | - Abdallah Farouk
- Department of Critical Care, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia,Department of Critical Care, Alexandria Faculty of Medicine, Alexandria, Egypt
| | - Amgad Awad
- Department of Nephrology and internal Medicine, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia,Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
| | - Waheed Mahdy
- Department of Critical Care, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia,Department of Chest Diseases, Banha Faculty of Medicine, Banha, Egypt
| | - Eman Abdelsalam
- Department of Internal Medicine, Al-Azhar Faculty of Medicine for Girls, Cairo, Egypt,Department of Internal Medicine, King Khalid Hospital, Hail, Saudi Arabia
| | - Sameh O Nour
- Department of Chest Diseases, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
| | - Sameh Makled
- Department of Chest Diseases, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
| | - Ahmed Shaarawy
- Department of Chest Diseases, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
| | - Hatem Kanany
- Department of Anesthesia and Critical Care, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
| | - Samer Qarah
- Department of Critical Care, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia
| | - Ahmed Kabil
- Department of Chest Diseases, Faculty of Medicine, Al-Azhar University, Cairo, Egypt,Correspondence: Ahmed Kabil, Department of Chest diseases, Al-Azhar University, Cairo, Egypt, Tel +201006396601, Email
| |
Collapse
|
4
|
Hashad N, Stewart D, Perumal D, Abdulrazzaq N, Tonna AP. The impact of COVID-19 on antimicrobial stewardship programme implementation in hospitals - an exploration informed by the Consolidated Framework for Implementation Research. J Hosp Infect 2022; 129:144-152. [PMID: 35998835 PMCID: PMC9396443 DOI: 10.1016/j.jhin.2022.08.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Revised: 08/15/2022] [Accepted: 08/15/2022] [Indexed: 11/19/2022]
Abstract
Introduction and objectives The disruption of antimicrobial stewardship programmes (ASPs) caused by coronavirus disease 2019 (COVID-19) has been recognized but not explored in depth. This study used a theoretical, qualitative approach to understand the impact of COVID-19 on ASP implementation in hospitals. Methods Semi-structured online interviews, informed by the Consolidated Framework for Implementation Research (CFIR), were conducted with ASP team members and non-members in hospitals. Participants were recruited via purposeful and snowball sampling with interviews video recorded, transcribed and analysed independently by two researchers based on mapping against CFIR constructs. Results Thirty-one interviews were conducted across 11 hospitals. The following themes were identified: (i) increased complexity of ASP implementation and changes in prescribing behaviour influenced by COVID-19; (ii) adaptations, networking and cosmopolitanism to enhance integration of COVID-19 management into ASP services; and (iii) adaptations and networking to support continuity of the ASP implementation process. A disruption to pre-pandemic ASP activities was reported, with complexity of COVID-19 overwhelming the healthcare system. ASP team members and services showed an ability to adapt and repurpose roles to respond to the pandemic. Interventions included developing national guidelines for treatment of patients with COVID-19 and contributing to guideline management and monitoring. A gradual restoration of ASP activities was perceived. Technological adaptations and enhancements in networking were reported as positive impacts of the pandemic. Conclusion Despite the initial disruption of ASP implementation caused by the pandemic, successful adaptation and evolution of ASP services reflects the high value and adaptability of ASP implementation in hospitals in the United Arab Emirates.
Collapse
Affiliation(s)
- N Hashad
- Pharmacy, Higher Colleges of Technology, Dubai, United Arab Emirates; Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK
| | - D Stewart
- College of Pharmacy, QU Health, Qatar University, Doha, Qatar
| | - D Perumal
- Commission of Academic Accreditation, Ministry of Education, Abu Dhabi, United Arab Emirates
| | - N Abdulrazzaq
- Al Kuwait Hospital, Emirates Health Services, Dubai, United Arab Emirates
| | - A P Tonna
- Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK.
| |
Collapse
|
5
|
Basem JI, Roth AF, White RS, Tangel VE, Jiang SY, Choi JM, Hoffman KL, Schenck EJ, Turnbull ZA, Pryor KO, Ivascu NS, Memtsoudis SG, Goldstein PA. Patient care in rapid-expansion intensive care units during the COVID-19 pandemic crisis. BMC Anesthesiol 2022; 22:209. [PMID: 35794523 PMCID: PMC9261025 DOI: 10.1186/s12871-022-01752-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Accepted: 06/23/2022] [Indexed: 12/20/2022] Open
Abstract
Background The coronavirus-2019 (COVID-19) pandemic highlighted the unfortunate reality that many hospitals have insufficient intensive care unit (ICU) capacity to meet massive, unanticipated increases in demand. To drastically increase ICU capacity, NewYork-Presbyterian/Weill Cornell Medical Center modified its existing operating rooms and post-anaesthesia care units during the initial expansion phase to accommodate the surge of critically ill patients. Methods This retrospective chart review examined patient care in non-standard Expansion ICUs as compared to standard ICUs. We compared clinical data between the two settings to determine whether the expeditious development and deployment of critical care resources during an evolving medical crisis could provide appropriate care. Results Sixty-six patients were admitted to Expansion ICUs from March 1st to April 30th, 2020 and 343 were admitted to standard ICUs. Most patients were male (70%), White (30%), 45–64 years old (35%), non-smokers (73%), had hypertension (58%), and were hospitalized for a median of 40 days. For patients that died, there was no difference in treatment management, but the Expansion cohort had a higher median ICU length of stay (q = 0.037) and ventilatory length (q = 0.015). The cohorts had similar rates of discharge to home, but the Expansion ICU cohort had higher rates of discharge to a rehabilitation facility and overall lower mortality. Conclusions We found no significantly worse outcomes for the Expansion ICU cohort compared to the standard ICU cohort at our institution during the COVID-19 pandemic, which demonstrates the feasibility of providing safe and effective care for patients in an Expansion ICU.
Collapse
Affiliation(s)
- Jade I Basem
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Anna F Roth
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Robert S White
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Virginia E Tangel
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Silis Y Jiang
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Jacky M Choi
- Department of Population Health Sciences, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY, USA
| | - Katherine L Hoffman
- Department of Population Health Sciences, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY, USA
| | - Edward J Schenck
- Department of Population Health Sciences, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY, USA
| | - Zachary A Turnbull
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Kane O Pryor
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Natalia S Ivascu
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA
| | - Stavros G Memtsoudis
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA.,Department of Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York, NY, USA
| | - Peter A Goldstein
- Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, Room A-1050, NY, 10065, New York, USA. .,Department of Medicine, Weill Cornell Medicine, New York, NY, USA. .,Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.
| |
Collapse
|